BIRCWH IV Program
- Mentors
- Scholars
BIRCWH II Program
- Mentors
- Scholars
Poster Day
- 2006 Poster Day
- 2007 Poster Day
Faculty
Grant Program
- Application Form
- Application Guidelines
- Grant Recipients
Symposia
Related Links
- University of Maryland Center for Research on Aging
- Research Center for Neuroendocrine Influences on Pain
- Maryland Women's Center
- University of Maryland Multidisciplinary Clinical Research Career Development Program
- NIH BIRCWH Program
Association of IP6-induced p27Kip1
Up-Regulation and Differentiation
of Breast Cancer Cells
Ivana Vucenik, PhD
School of Medicine, University of Maryland, Baltimore
Inositol hexaphosphate (IP6) is a common constituent of grains and cereals and an active component responsible for the anticancer effect of the high-fiber diet. A striking anticancer action of IP6 has been demonstrated in various models, including breast cancer. In in vitro models, IP6 inhibits tumor cell growth and increases differentiation of malignant cells, causing the cancer cells to mature, become less aggressive and behave like normal cells. However, the mechanism of this action is still not known.
Based on our preliminary data, we hypothesize that the anti-proliferative effects of IP6 are mediated by up-regulation of p27Kip1 through activation of protein kinase C (PKC)d. To test this hypothesis in this proposal, we are planning to address questions: (1) Is IP6-induced activation of PKCd; involved in this up-regulation of p27Kip1, and (2) How important is the up-regulation of the p27Kip1 in the IP6-induced differentiation?
The results of this proposal may have some potentially important therapeutic consequences, since (a) p27Kip1 is a critical intrinsic brake of the cell cycle engine. Deregulation of p27Kip1 expression is a relatively common feature of many solid tumors. Total or partial loss of p27Kip1 expression in tumor cells may have important implications in breast cancer, since it has been shown that patients with high levels of p27Kip1 have a good prognosis, compared to those with low levels; (b) Targeting some members of the PKC signal transduction pathways can be important in anti-tumor therapeutic strategy; and (c) Differentiation therapy could be offered as an alternate for the treatment of breast cancer.
Therefore, the proposed studies might have a great impact on the course of breast cancer, providing a basis for novel strategies and novel alternative therapeutic protocols in the treatment and prevention of this dreadful disease.
